The convalescent plasma Expanded Access Program for the treatment of COVID-19 extends its gratitude to participating acute care facilities, blood collection centers and health care providers for providing access to a potential therapy for COVID-19.

See the list
This content does not have an English version.
This content does not have an Arabic version.

Protocol - Convalescent Plasma COVID-19 (Coronavirus) Treatment

Home For physicians

Protocol

Reference or download the documents below. Contact our office with any questions: uscovidplasma@mayo.edu

R Scott Wright, M.D.

Senior Chair and Medical Director, Mayo Clinic Institutional Review Board

Director, Mayo Clinic Human Research Protection Program

Photo of R Scott Wright, M.D.

Download Protocol Documents (PDF’s):

  • Protocol document

    Published August 10, 2020

  • Protocol appendix 1

    Published August 10, 2020

  • Clinical Investigator’s Brochure

    Published July 15, 2020